Calendar Taro Pharmaceutical Industries Ltd.

Equities

TARO

IL0010827181

Market Closed - Nyse Other stock markets 21:00:02 21/06/2024 BST			5-day change	1st Jan Change
42.97 ^USD	0.00%		+0.37%	+2.85%

06-25	Taro Pharmaceutical Industries Ltd.(NYSE:TARO) dropped from S&P Global BMI Index	CI
06-24	Sun Pharmaceutical Industries Limited acquired remaining 21.5% stake in Taro Pharmaceutical Industries Ltd. from Krensavage Asset Management, LLC and others for approximately	CI

Chart calendar Taro Pharmaceutical Industries Ltd.

44a33ad17d0a45cd35d94f06d306db.fQVzPvMmGg1tEVocaoNq7unY1ARUOSinXh6awuBZZzk.DFxHV7VPbkdUfhh9KPcypN-euXwjbH7lGkqs87YbUmsOQQZEuUNcfy5rPQ~b00d2eb9e730670a13f27fd825f4533f

Upcoming events on Taro Pharmaceutical Industries Ltd.

23/07/2024	Q1 2025 Earnings Release (Projected)
23/10/2024	Q2 2025 Earnings Release (Projected)
22/01/2025	Q3 2025 Earnings Release (Projected)
26/05/2025	Q4 2025 Earnings Release (Projected)

Past events on Taro Pharmaceutical Industries Ltd.

22/05/2024 09:00	Shareholders Meeting
22/05/2024 08:00	Extraordinary Shareholders Meeting
20/05/2024 22:00	Q4 2024 Earnings Release
25/01/2024 22:06	Q3 2024 Earnings Release
28/12/2023 09:00	Annual General Meeting
26/10/2023 22:00	Q2 2024 Earnings Release
27/07/2023 01:36	Q1 2024 Earnings Release
24/05/2023 00:00	Q4 2023 Earnings Release
24/01/2023 22:43	Q3 2023 Earnings Release
27/10/2022 23:39	Interim 2023 Earnings Release
27/07/2022 22:28	Q1 2023 Earnings Release
27/05/2022 00:00	FY 2022 Earnings Release
27/01/2022 22:00	Q3 2022 Earnings Release
28/10/2021 22:15	Interim 2022 Earnings Release
28/07/2021 00:28	Q1 2022 Earnings Release
19/05/2021 22:30	FY 2021 Earnings Release
27/01/2021 22:46	Q3 2021 Earnings Release
14/12/2020 08:00	Annual General Meeting
29/10/2020 12:00	Interim 2021 Earnings Call
28/10/2020 21:15	Interim 2021 Earnings Release

Past dividends on Taro Pharmaceutical Industries Ltd.

09/12/2018

12.81 USD

Annual results

Fiscal Period	March	2019	2020	2021	2022	2023	2024
Net sales Million USD	Released Forecast Spread	670 697 -3.83%	645 638 1.05%	549 548 0.19%	561 565 -0.66%	573 577 -0.71%	629 618 1.8%
EBITDA Million USD	Released Forecast Spread	311 375 -17.1%	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -
EBIT Million USD	Released Forecast Spread	293 341 -14.18%	247 259 -4.72%	145 -331 143.82%	125 81,8 52.76%	17,7 13,8 28.75%	21,5 -1,24 1831.27%
Earnings before Tax (EBT) Million USD	Released Forecast Spread	357 365 -2.34%	298 306 -2.54%	-391 -308 -26.91%	77,9 94,9 -17.99%	38,2 31,2 22.36%	82,7 53,5 54.41%
Net income Million USD	Released Forecast Spread	282 275 2.64%	244 249 -1.81%	-387 -322 -20.21%	58,3 63,7 -8.52%	25,4 27,0 -5.92%	53,9 41,4 30.08%
EPS USD	Released Forecast Spread	7,23 7,98 -9.39%	6,35 6,47 -1.85%	-10,1 -8,41 -20.33%	1,55 1,70 -8.82%	0,68 0,72 -5.56%	1,43 1,10 30%
Announcement Date		22/05/19	19/05/20	19/05/21	27/05/22	24/05/23	20/05/24

Quarterly results

Fiscal Period	March	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4
Net sales Million USD	Released Forecast Spread	148 147 0.69%	147 137 7.2%	132 153 -13.86%	139 142 -2.28%	143 147 -2.55%	157 150 4.51%	130 161 -18.96%	139 163 -14.66%	147 151 -2.72%	159 149 6.62%	161	155	156
EBIT Million USD	Released Forecast Spread	38,1 40,7 -6.25%	40,8 36,8 10.73%	24,4 45,5 -46.32%	37,0 39,6 -6.76%	21,3 39,6 -46.26%	14,0 37,9 -63.15%	-6,82 37,0 -118.44%	1,28 36,7 -96.52%	9,27 5,32 74.36%	-1,70 7,02 -124.21%	-1,10	1,03	0,91
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-37,8 45,2 -183.62%	-16,1 40,8 -139.36%	29,4 49,3 -40.37%	39,5 43,6 -9.49%	25,0 42,1 -40.57%	16,1 41,0 -60.87%	-4,91 40,5 -112.15%	9,17 41,5 -77.91%	17,9 10,9 63.93%	5,44 15,3 -64.5%	8,90	15,0	15,4
Net income Million USD	Released Forecast Spread	-29,8 35,2 -184.57%	-18,8 31,9 -158.9%	23,3 38,5 -39.41%	26,3 34,0 -22.71%	27,4 32,8 -16.53%	14,1 32,0 -56.01%	-2,81 31,6 -108.92%	7,27 32,4 -77.57%	6,91 8,52 -18.83%	10,0 11,5 -12.7%	6,68	11,3	11,6
EPS USD	Released Forecast Spread	-0,78 0,92 -184.78%	-0,50 0,84 -159.52%	0,62 1,02 -39.22%	0,70 0,91 -23.08%	0,73 0,88 -17.05%	0,37 0,85 -56.47%	-0,07 0,84 -108.33%	0,19 0,87 -78.16%	0,18 0,23 -21.74%	0,27 0,31 -12.9%	0,18	0,30	0,31
Announcement Date		19/05/21	27/07/21	28/10/21	27/01/22	27/05/22	27/07/22	27/10/22	24/01/23	24/05/23	27/07/23	-	-	-

Upcoming sector events for Taro Pharmaceutical Industries Ltd.

03/07/2024	HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2024 Earnings Release (Projected)
10/07/2024	HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release
15/07/2024	CAMURUS AB: Q2 2024 Earnings Release
16/07/2024	GLAND PHARMA LIMITED: Q1 2025 Earnings Release (Projected)
17/07/2024 11:45	JOHNSON & JOHNSON: Q2 2024 Earnings Release
17/07/2024	JUBILANT PHARMOVA LIMITED: Q1 2025 Earnings Release (Projected)
18/07/2024 06:00	NOVARTIS AG: Q2 2024 Earnings Release
21/07/2024	GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected)
21/07/2024	ALMIRALL, S.A.: Q2 2024 Earnings Release
22/07/2024	TORRENT PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected)

More events

Past sector events for Taro Pharmaceutical Industries Ltd.

21/06/2024 16:28	DEVA HOLDING: Q1 2024 Earnings Release
13/06/2024 22:21	EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release
11/06/2024 06:30	BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release
07/06/2024 11:33	SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release
07/06/2024 10:17	LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release
30/05/2024 13:08	SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release
30/05/2024 12:00	ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release
30/05/2024 07:24	MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release
29/05/2024 13:00	FDC LIMITED: Q4 2024 Earnings Release
29/05/2024 10:26	JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release